면역적격환자에서 발생한 위막성 아스페르길루스 기관기관지염 1예

Pseudomembranous Aspergillus Tracheobronchitis in an Immunocompetent Patient

  • 차승익 (경북대학교 의학전문대학원 내과학교실) ;
  • 신경민 (경북대학교 의학전문대학원 영상의학교실) ;
  • 유승수 (경북대학교 의학전문대학원 내과학교실) ;
  • 정지윤 (경북대학교 의학전문대학원 병리학교실) ;
  • 윤길숙 (경북대학교 의학전문대학원 병리학교실) ;
  • 이신엽 (경북대학교 의학전문대학원 내과학교실) ;
  • 김창호 (경북대학교 의학전문대학원 내과학교실) ;
  • 박재용 (경북대학교 의학전문대학원 내과학교실) ;
  • 정태훈 (경북대학교 의학전문대학원 내과학교실)
  • Cha, Seung-Ick (Department of Internal Medicine, Kyungpook National University School of Medicine) ;
  • Shin, Kyung-Min (Department of Radiology, Kyungpook National University School of Medicine) ;
  • Yoo, Seung-Soo (Department of Internal Medicine, Kyungpook National University School of Medicine) ;
  • Jeong, Ji-Yun (Department of Pathology, Kyungpook National University School of Medicine) ;
  • Yoon, Ghil-Suk (Department of Pathology, Kyungpook National University School of Medicine) ;
  • Lee, Shin-Yeop (Department of Internal Medicine, Kyungpook National University School of Medicine) ;
  • Kim, Chang-Ho (Department of Internal Medicine, Kyungpook National University School of Medicine) ;
  • Park, Jae-Yong (Department of Internal Medicine, Kyungpook National University School of Medicine) ;
  • Jung, Tae-Hoon (Department of Internal Medicine, Kyungpook National University School of Medicine)
  • 투고 : 2008.10.08
  • 심사 : 2008.10.30
  • 발행 : 2008.11.30

초록

아스페르길루스 기관기관지염은 침습적 폐 아스페르길루스증의 일종으로 심한 기관기관지염과 위막형성을 특징으로 한다. 이 질환은 일반적으로 면역억제 환자에서 발생하며 치명률이 높은 질환이다. 저자들은 비교적 건강하던 환자에서 발생하였고 항진균제에 잘 반응하였던 아스페르길루스 기관기관지염을 1예 경험하였기에 보고하는 바이다.

Aspergillus tracheobronchitis (ATB), a variant of invasive pulmonary aspergillosis, is characterized by extensive tracheobronchitis and pseudomembrane formation. ATB usually occurs in immunocompromised patients with a high fatality rate. We report a case of ATB in a previously healthy patient who responded well to antifungal therapy.

키워드

참고문헌

  1. Soubani AO, Chandrasekar PH. The clinical spectrum of pulmonary aspergillosis. Chest 2002;121:1988-99. https://doi.org/10.1378/chest.121.6.1988
  2. Sharma OP, Chwogule R. Many faces of pulmonary aspergillosis. Eur Respir J 1998;12:705-15. https://doi.org/10.1183/09031936.98.12030705
  3. Routsi C, Platsouka E, Prekates A, Rontogianni D, Paniara O, Roussos C. Aspergillus bronchitis causing atelectasis and acute respiratory failure in an immunocompromised patient. Infection 2001;29:243-4. https://doi.org/10.1007/s15010-001-1148-0
  4. Routsi C, Kaltsas P, Bessis E, Rontogianni D, Kollias S, Roussos C. Airway obstruction and acute respiratory failure due to Aspergillus tracheobronchitis. Crit Care Med 2004;32:580-2. https://doi.org/10.1097/01.CCM.0000110724.86196.3B
  5. Tasci S, Glasmacher A, Lentini S, Tschubel K, Ewig S, Molitor E, et al. Pseudomembranous and obstructive Aspergillus tracheobronchitis - optimal diagnostic strategy and outcome. Mycoses 2006;49:37-42.
  6. Machida U, Kami M, Kanda Y, Takeuchi K, Akahane M, Yamaguchi I, et al. Aspergillus tracheobronchitis after allogeneic bone marrow transplantation. Bone Marrow Transplant 1999;24:1145-9. https://doi.org/10.1038/sj.bmt.1702030
  7. van Assen S, Bootsma GP, Verweij PE, Donnelly JP, Raemakers JM. Aspergillus tracheobronchitis after allogeneic bone marrow transplantation. Bone Marrow Transplant 2000;26:1131-2. https://doi.org/10.1038/sj.bmt.1702679
  8. Boots RJ, Paterson DL, Allworth AM, Faoagali JL. Successful treatment of post-influenza pseudomembranous necrotising bronchial aspergillosis with liposomal amphotericin, inhaled amphotericin B, gamma interferon and GM-CSF. Thorax 1999;54:1047-9. https://doi.org/10.1136/thx.54.11.1047
  9. Franco J, Munoz C, Vila B, Marin J. Pseudomembranous invasive tracheobronchial aspergillosis. Thorax 2004;59:452. https://doi.org/10.1136/thx.2004.022046
  10. Nicholson AG, Sim KM, Keogh BF, Corrin B. Pseudomembranous necrotising bronchial aspergillosis complicating chronic airways limitation. Thorax 1995;50:807-8. https://doi.org/10.1136/thx.50.7.807
  11. Chang SM, Kuo HT, Lin FJ, Tzen CY, Sheu CY. Pseudomembranous tracheobronchitis caused by Aspergillus in immunocompromised patients. Scand J Infect Dis 2005;37:937-42. https://doi.org/10.1080/00365540510044445
  12. Denning DW. Commentary: unusual manifestations of aspergillosis. Thorax 1995;50:812-3. https://doi.org/10.1136/thx.50.7.812
  13. Bulpa PA, Dive AM, Garrino MG, Delos MA, Gonzalez MR, Evrard PA, et al. Chronic obstructive pulmonary disease patients with invasive pulmonary aspergillosis: benefits of intensive care? Intensive Care Med 2001;27:59-67. https://doi.org/10.1007/s001340000768